Skip to main content
  • nl
  • fr
  • en
Other official information and services: www.belgium.be
Logo of the Belgian Federal Authorities
Return to the FAMHP homepage
Your medicine and health products
  • About the FAMHP
  • Jobs
  • Publications
  • Press
  • Contact
  • Complaints
  • Webportal
  • Home
  • Human medicines
  • Veterinary medicines
    • Medicines
      • Medicines
        • Scientific-Technical Advice
        • Research & Development
        • Marketing Authorisation procedures
          • Types
          • Requirements
          • eSubmission
            • VNees checkers V 2_5b
            • VNees checkers and toc builders V2_2
            • VNees checkers and toc builders V2_4b
            • VNees checkers and toc builders v2_3
          • Parallel import
          • MRL
          • Practical informations
        • Pharmacovigilance
        • Production
        • Distribution & delivery
        • Authorisation - Certificates
        • Declarations
        • Proper use
    • Particular products
    • Health products
  • Information for the public
  • Notification of adverse reactions or incidents
  • Home
  • Veterinary medicines
  • Medicines
  • Medicines
  • Marketing Authorisation procedures
  • eSubmission
  • VNees checkers and toc builders V2_2
  • Medicines
    • Medicines
  • Particular products
    • Raw materials
    • Specially reglemented substances
    • Grey area
  • Health products
    • Medical devices and their accessories

VNees checkers and toc builders V2_2

  • VNees checker 2.2

 

  • Light VNees checker 2.2

 

  • VNees toc builder full installer 2.2

 

  • Light VNees toc builder installer 2.2
Last updated on 28/04/2015

Notification of adverse reactions or incidents

PIL and SPC
of a medicine

(PIL: patient information leaflet SPC: summary of product characteristics)

Search

News

12/02/2019
New verification system against falsified medicines in each link in the distribution chain
12/02/2019
Practical recommendations for the new verification systems against falsified medications
30/01/2019
Flash VIG-news: LYNPARZA® (olaparib): risk of medication errors with new pharmaceutical form
29/01/2019
Notifications about anti-tampering device (ATD) or devices to prevent tampering on packaging of existing drugs that do not fall under the Falsified Medicines Directive
All news

© 2016 - FAMHP

  • Site map
  • Disclaimer
  • Complaints
  • Contact